Valuation: CSPC Innovation Pharmaceutical Co., Ltd.

Capitalization 7.08TCr 987.24Cr 844.19Cr 786.34Cr 731.37Cr 1.35TCr 85TCr 1.5TCr 9.42TCr 3.6TCr 40TCr 3.7TCr 3.63TCr 1,45500Cr P/E ratio 2025 *
161x
P/E ratio 2026 * 87.8x
Enterprise value 7.02TCr 979.23Cr 837.34Cr 779.95Cr 725.43Cr 1.34TCr 84TCr 1.49TCr 9.35TCr 3.57TCr 39TCr 3.67TCr 3.6TCr 1,44300Cr EV / Sales 2025 *
21.7x
EV / Sales 2026 * 14.8x
Free-Float
21.43%
Yield 2025 *
0.24%
Yield 2026 * 0.59%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.26%
1 week-2.42%
Current month-1.68%
1 month-15.50%
3 months+22.72%
6 months+98.98%
Current year+91.12%
More quotes
1 week 49.65
Extreme 49.65
53.09
1 month 49.65
Extreme 49.65
61.07
Current year 22.02
Extreme 22.02
63.31
1 year 21.07
Extreme 21.07
63.31
3 years 5.92
Extreme 5.9213
63.31
5 years 5.36
Extreme 5.3611
63.31
10 years 4.98
Extreme 4.979
63.31
More quotes
Manager TitleAgeSince
Chief Executive Officer 48 22/04/2024
Director of Finance/CFO 33 07/04/2023
Director TitleAgeSince
Director/Board Member 51 01/01/2016
Chairman 49 01/01/2016
Director/Board Member 45 07/09/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.26%-2.42%+118.77%+574.69% 974.16Cr
-0.18%-1.27%+10.93%+2.01% 936.4Cr
-0.60%+0.94%+4.75%+145.21% 740.26Cr
+1.49%+3.70%-10.67%-10.45% 324.8Cr
+0.87%+1.67%-10.64%-44.20% 269.59Cr
-0.25%-3.93%+45.45%-15.67% 168.83Cr
-1.40%-1.98%+11.50%-0.40% 106.95Cr
-0.92%+6.17%-3.35%-48.07% 105.62Cr
0.00%+1.18%+149.28%+10.26% 105.29Cr
-1.96%+8.56%+285.02%+146.37% 104.77Cr
Average -0.17%+1.33%+60.10%+75.97% 383.67Cr
Weighted average by Cap. +0.22%+0.36%+46.20%+172.69%
See all sector performances

Financials

2025 *2026 *
Net sales 322.8Cr 45Cr 39Cr 36Cr 33Cr 62Cr 3.86TCr 68Cr 429.76Cr 164.31Cr 1.81TCr 168.88Cr 165.4Cr 6.64TCr 470.92Cr 66Cr 56Cr 52Cr 49Cr 90Cr 5.64TCr 100Cr 626.96Cr 239.71Cr 2.64TCr 246.38Cr 241.3Cr 9.68TCr
Net income 50Cr 6.93Cr 5.93Cr 5.52Cr 5.14Cr 9.49Cr 594.87Cr 11Cr 66Cr 25Cr 278.53Cr 26Cr 25Cr 1.02TCr 97Cr 13Cr 12Cr 11Cr 9.99Cr 18Cr 1.16TCr 21Cr 128.69Cr 49Cr 541.72Cr 51Cr 50Cr 1.99TCr
Net Debt -57Cr -8.02Cr -6.86Cr -6.39Cr -5.94Cr -11Cr -687.95Cr -12Cr -77Cr -29Cr -322.11Cr -30Cr -29Cr -1.18TCr -123.71Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.48TCr -26Cr -164.71Cr -63Cr -693.32Cr -65Cr -63Cr -2.54TCr
More financial data * Estimated data
Logo CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.
Employees
2,487
More about the company
Date Price Change Volume
11/25/11 50.82 ¥ +1.26% 42,25,019
10/25/10 50.19 ¥ -0.59% 38,17,305
09/25/09 50.49 ¥ +0.30% 45,29,967
08/25/08 50.34 ¥ -1.76% 57,12,975
07/25/07 51.24 ¥ -2.27% 43,35,360

End-of-day quote Shenzhen S.E., July 11, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
50.82CNY
Average target price
51.40CNY
Spread / Average Target
+1.14%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300765 Stock